News Releases Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Go Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Go Email Alerts Year All Years 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 Keywords Go Advanced Search Keywords Search Headlines Only From To Asset Types Photos Video Audio Documents Events Standard Dec 6, 2007 Insmed Appoints Dennis M. Lanfear to Board Of Directors Dec 3, 2007 Insmed Retains FD and Gibraltar Associates for Investor Relations and Corporate Communications Nov 13, 2007 Insmed Advances Follow on Biologics Initiative Nov 8, 2007 Insmed Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2007 Nov 5, 2007 Insmed Announces Initiation of Phase II Clinical Trial with IPLEX(TM) in Myotonic Muscular Dystrophy Oct 24, 2007 Insmed Announces Third Quarter Earnings Release Date and Conference Call Oct 23, 2007 Insmed to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference Oct 3, 2007 Insmed to Present at the 2007 BIO Investor Forum on Wednesday, October 10, 2007 Aug 2, 2007 Insmed Reports Financial Results for Second Quarter and First Half of 2007 Jul 25, 2007 Insmed Announces Second Quarter and First Half Earnings Release Date and Conference Call Jul 9, 2007 Insmed Inc. to Present at C.E. Unterberg, Towbin Growth Conference Jun 26, 2007 Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature Infants Jun 25, 2007 Experienced Biopharmaceutical Executive Steve Glover Joins Insmed; Will Lead Development of Follow-on Biologics Jun 19, 2007 Insmed Receives NASDAQ Deficiency Notice Relating to Minimum Bid Price May 10, 2007 Insmed Incorporated Reports Financial Results for First Quarter Ended March 31, 2007 May 7, 2007 Insmed Announces First Quarter Earnings Release Date and Conference Call May 4, 2007 Insmed Raises Approximately $18.2 Million in Registered Direct Offering May 3, 2007 Insmed Announces Promising Results From IPLEX Phase II Myotonic Muscular Dystrophy Clinical Study May 2, 2007 Insmed CEO Geoffrey Allan Testifies at Energy and Commerce Committee Hearing Apr 30, 2007 Insmed Releases Positive Results from IPLEX Phase II HIV-Associated Adipose Redistribution Syndrome Clinical Study Apr 25, 2007 Insmed Inc. Releases Investor Fact Sheet with Updates on Drug Development Progress Mar 26, 2007 Insmed CEO Geoffrey Allan Testifies at Congressional Hearing Mar 16, 2007 Insmed Announces Additional Information In Compliance With NASDAQ Rules Mar 15, 2007 Insmed Inc. Reports Financial Results for Fourth Quarter and Twelve Months Mar 10, 2007 Update: Insmed to Hold 2006 Q4 and Year End Earnings Results Show 5102550100 per page«1…17181920212223…28» Stay In The Loop Want to stay up to date on our news, events, and filings? Set up your email alerts. Sign Up View the latest Insmed Investor Presentation Download